Company News in the Life Science Industry

NEW YORK, May 24, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) today celebrated the decision by the U.S. Food and Drug Administration (FDA) to grant approval of Zolgensma (onasemnogene abeparvovac-xioi), the first gene therapy for a neuromuscular disease. Zolgensma is a one-time... Read more ››

DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35(th) Annual Strategic Decisions Conference in New York, NY. The presentation will begin at 4:00 p.m. Eastern Time on Thursday,... Read more ››

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

BOSTON, May 24, 2019 /PRNewswire/ -- In response to the Trump Administration's proposal to eliminate health care protections for transgender people, Andrew Dreyfus, president & CEO of Blue Cross Blue Shield of Massachusetts, released the following statement:

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

SILVER SPRING, Md., May 24, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Piqray (alpelisib) tablets, to be used in combination with the FDA-approved endocrine therapy fulvestrant, to treat postmenopausal women, and men, with hormone receptor (HR)-positive, human... Read more ››

DUBLIN, May 24, 2019 /PRNewswire/ -- The Read more ››

BRENTWOOD, Tenn., May 24, 2019 /PRNewswire/ -- Ahead of the holiday, American Addiction Centers (NYSE: AAC) reminds people to keep their sober friends in mind during their weekend gatherings. Memorial Day weekend is usually considered the unofficial start of summer with the arrival of sunny,... Read more ››

EAST HANOVER, N.J., May 24, 2019 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray(®) (alpelisib, formerly BYL719) in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor positive, human epidermal... Read more ››

PHILADELPHIA, May 24, 2019 /PRNewswire/ -- James Wilson, MD, PhD, recalls being struck by the devastating... Read more ››